380550 — Neurophet Cashflow Statement
0.000.00%
- KR₩232bn
- KR₩214bn
- KR₩3bn
Annual cashflow statement for Neurophet, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | — | 5,263 | -15,101 | -22,389 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | — | -15,903 | 1,063 | 6,750 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -7,931 | 640 | 331 | -538 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -7,931 | -8,974 | -12,613 | -15,067 |
| Capital Expenditures | -354 | -313 | -393 | -325 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 7,610 | -5,621 | 9,011 | -16,033 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Sale of Intangible Assets | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 7,256 | -5,934 | 8,618 | -16,357 |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 264 | 19,753 | 342 | 32,516 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -412 | 4,845 | -3,652 | 1,084 |